Anika Therapeutics
- ANIK
- NASDAQ
- Consumer Products
- Latest 17.55
- Currency US$
- Change 1.00
- Percent Change 6.042 %
- Volume 216,923
- Tue Jun 18, 2013 4:00 PM EDT NASDAQ data delayed 15 minutes.
The Globe and Mail
- Open 16.65
- Previous Close 16.55
- High 17.78
- Low 16.465
- Bidx1 14.38
- Askx3 20.00
- 52-week High 06/17 16.885
- 52-week Low 12/05 9.13
- Beta 1.317
- Market Cap 244.30M
- EPS 0.89
- P/E 19.72
- Forward P/E 13.50
- PEG --
- Annual Dividend --
- Yield --
News
- Anika Therapeutics Reports First-Quarter 2013 Financial Results
- Anika Therapeutics Announces Date of First-Quarter 2013 Financial Results Conference Call
- Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on March 19
- Anika Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results
- Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2012 Financial Results Conference Call
Financials & Calendars
- Sales $72,260,000
- Earnings $12,910,000
- Return on Equity 11.64%
- Cash Flow --
- Cash $50,960,000
- Current Ratio 7.33
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $141,350,000
- Liabilities $28,530,000
- Liabilities-to-Equity Ratio 0.25
Price Ratios
- Price to Sales 3.38
- Price to Book 2.17
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | May 1 | $0.17 | Aug 7 | $0.29 |
| Surprises | May 1 | 23.53% | n/a | n/a |
| Dividends | n/a | n/a | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended Jun 19, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products and devices that promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid, a naturally-occurring, biocompatible polymer found in the body. Due to its unique properties, hyaluronic acid plays an important role in numerous physiological functions such as the protection and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues and the transport of molecules to and within cells.
Officers
- Charles H. Sherwood, Ph.D. Chief Executive Officer and Di
- Kevin W. Quinlan Chief Financial Officer
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Head Office
236 WEST CUMMINGS PARKWOBURN, MA
01801
Phone: 6179326616
Fax: (781)-3059720
Investorrelations@anikatherapeutics.com
www.anikatherapeutics.com
Ideas & Discussion
Live Discussion of ANIK on StockTwits